Two thousand two hundred twelve study patients were, on average, 63.0 years old, 69.9% of them were men, and 61.9% had a nonsquamous cell carcinoma. During the 2 years after nivolumab treatment ...
Two posters presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exhibition focused on overall survival associated with real-world treatment sequences in patients with chronic ...
The complexity and heterogeneity of protein therapeutics present significant challenges in biologics discovery, as ...
With a newly developed method that compares AI-generated protein sequences with naturally occurring ones, function- and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback